{
    "clinical_study": {
        "@rank": "168068", 
        "acronym": "DiNA", 
        "arm_group": [
            {
                "arm_group_label": "pure galactose", 
                "arm_group_type": "Active Comparator", 
                "description": "5 grams of galactose, three times a day with the main meals, duration: 4 weeks"
            }, 
            {
                "arm_group_label": "pure palatinose", 
                "arm_group_type": "Placebo Comparator", 
                "description": "5 grams of palatinose, three times a day with the main meals, duration: 4 weeks"
            }, 
            {
                "arm_group_label": "soluble non-fermentable fibers", 
                "arm_group_type": "Placebo Comparator", 
                "description": "5 grams of soluble non-fermentable fibers, three times a day with the main meals, duration: 4 weeks"
            }, 
            {
                "arm_group_label": "non-soluble non-fermentable fibers", 
                "arm_group_type": "Active Comparator", 
                "description": "5 grams of non-soluble non-fermentable fibers, three times a day with each main meal, duration: 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "In animal models and retrospective studies, certain food components such as sugars and fiber\n      have been detected as potential agents to influence development and progress of type 2\n      diabetes.\n\n      The DiNA study prospectively investigates, if non-soluble non-fermentable fibers (vs.\n      soluble ones) and galactose (vs. palatinose) are capable to improvement metabolic parameters\n      in patients with long-term type 2 diabetes and intensive insulin treatment."
        }, 
        "brief_title": "Diabetes Nutrition Algorithms - Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  type 2 diabetes, insulin-dependent\n\n          -  high insulin resistance\n\n        Exclusion Criteria:\n\n          -  accompanying disease, medication or metabolic disorder, which interact with glucose\n             metabolism or eating behavior (e.g. renal insufficiency, major cardial insuffiency,\n             untreated hypothyreosis, corticoid treatment, depression and other psychiatric\n             disorders...)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01776099", 
            "org_study_id": "DiNA-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "pure galactose", 
                "pure palatinose", 
                "soluble non-fermentable fibers", 
                "non-soluble non-fermentable fibers"
            ], 
            "intervention_name": "Dietary supplement (4 arms, 2 active, 2 placebo)", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "type 2 diabetes", 
            "nutrition", 
            "fibers"
        ], 
        "lastchanged_date": "January 23, 2013", 
        "location": {
            "contact": {
                "email": "stefan.kabisch@charite.de", 
                "last_name": "Stefan Kabisch", 
                "phone": "030 8445 3474"
            }, 
            "contact_backup": {
                "email": "diabetes@charite.de"
            }, 
            "facility": {
                "address": {
                    "city": "Berlin", 
                    "country": "Germany", 
                    "zip": "12203"
                }, 
                "name": "Charit\u00e9-Klinikum Benjamin Franklin"
            }, 
            "investigator": {
                "last_name": "Stefan Kabisch", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "Diabetes Nutrition Algorithms - Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes", 
        "overall_contact": {
            "email": "stefan.kabisch@charite.de", 
            "last_name": "Stefan Kabisch", 
            "phone": "030 8445 3474"
        }, 
        "overall_contact_backup": {
            "email": "diabetes@charite.de", 
            "last_name": "Gabriele Klampke"
        }, 
        "overall_official": {
            "affiliation": "German Institute for Human Nutrition", 
            "last_name": "Andreas F.H. Pfeiffer, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "metabolic improvement of type 2 diabetes, as to be shown via hyperinsulinemic-euglycaemic clamp, mixed-meal test and daily demand of insulin units", 
            "measure": "metabolic improvement of type 2 diabetes", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01776099"
        }, 
        "responsible_party": {
            "investigator_affiliation": "German Institute of Human Nutrition", 
            "investigator_full_name": "Prof. Dr. med. Andreas F. H. Pfeiffer", 
            "investigator_title": "Director of the Department for Clinical Nutrition", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "German Institute of Human Nutrition", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Deutsche Diabetes Gesellschaft (German Diabetes Society)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Firma Rettenmeier & S\u00f6hne (Company)", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "German Institute of Human Nutrition", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}